close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar78Point53
Implied share price

Buy Undervalued by 11.9%

5% margin of safety What's this?

EV / EBITDA
Use Average
AMGN
Amgen, Inc.
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
NVO
Novo Nordisk A/S (ADR)
Change
AZN
AstraZeneca plc (ADR)
Change
8.11 7.26 17.08 4.63 3.06 3.43
All amounts in millions
from last financial year
         
Implied Share Price $78.53 $46.78 $66.53 $333.77 $97.65
Market Cap 54,595 100,042 92,468 63,865 54,061
Net Debt 787 -3,369 11,280 -16,649 -2,491
Enterprise Value (EV) 55,382 96,673 56,670 76,452 51,375
Revenue 15,582 13,418 35,058 66,346 33,591
EBITDA 7,627 5,661 12,249 24,983 14,993
Percent 48.9 % 42.2 % 34.9 % 37.7 % 44.6 %
EBIT 6,568 5,069 7,674 22,493 12,996
Percent 42.2 % 37.8 % 21.9 % 33.9 % 38.7 %
Balance Sheet          
Total Assets 48,871 21,787 100,165 64,698 52,830
Total Liabilities 29,842 6,116 43,946 27,250 29,584
Shareholders Equity 19,029 15,671 56,219 37,448 23,246.0

Comments

No comments yet. Login to comment.